Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer

Publication Date: April 2, 2018

Last Updated: March 27, 2023

Treatment

ADT + Docetaxel

For men with metastatic non-castrate prostate cancer with high volume disease per CHAARTED who are candidates for treatment with chemotherapy, the addition of docetaxel to ADT should be offered. (EB, H, S)

Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer

Treatment

ADT + Docetaxel

Overview

Title

Authoring Organization